Schneider Eugene (CIK 1838539) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-30). Recent activity: Buy IONS (26,000 shares), Sell IONS (26,000 shares), Sell IONS (5,812 shares), Buy IONS (11,991 shares), Sell IONS (6,179 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-30 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Buy | 26,000 | $1.6M |
| 2026-06-30 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Sell | 26,000 | $2.1M |
| 2026-03-23 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Sell | 5,812 | $412,478 |
| 2026-02-02 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Buy | 11,991 | $0 |
| 2026-02-02 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Sell | 6,179 | $515,638 |
| 2026-01-20 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Buy | 21,685 | $0 |
| 2026-01-20 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Sell | 9,302 | $703,138 |
| 2025-09-04 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Buy | 19,658 | $1.1M |
| 2025-09-04 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Sell | 12,455 | $753,029 |
| 2025-09-04 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Sell | 7,203 | $442,408 |
| 2025-08-05 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Sell | 9,549 | $408,697 |
| 2025-02-03 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Buy | 4,032 | $0 |
| 2025-02-03 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Sell | 1,484 | $47,785 |
| 2025-01-17 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Buy | 17,372 | $0 |
| 2025-01-17 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf Clinical Develop Ofcr | Sell | 6,523 | $213,889 |
Source: SEC Form 4 filings · as of 2026-06-30